Grijota Martínez, M. d. C., Montero-Pedrazuela, A., Hidalgo-Álvarez, J., Bárez-López, S., & Guadaño-Ferraz, A. (2023). Intracerebroventricular High Doses of 3,3′,5-Triiodothyroacetic Acid at Juvenile Stages Improve Peripheral Hyperthyroidism and Mediate Thyromimetic Effects in Limited Brain Regions in a Mouse Model of Monocarboxylate Transporter 8 Deficiency.
Citación estilo ChicagoGrijota Martínez, María del Carmen, Ana Montero-Pedrazuela, Jorge Hidalgo-Álvarez, Soledad Bárez-López, y Ana Guadaño-Ferraz. Intracerebroventricular High Doses of 3,3′,5-Triiodothyroacetic Acid At Juvenile Stages Improve Peripheral Hyperthyroidism and Mediate Thyromimetic Effects in Limited Brain Regions in a Mouse Model of Monocarboxylate Transporter 8 Deficiency. 2023.
Cita MLAGrijota Martínez, María del Carmen, et al. Intracerebroventricular High Doses of 3,3′,5-Triiodothyroacetic Acid At Juvenile Stages Improve Peripheral Hyperthyroidism and Mediate Thyromimetic Effects in Limited Brain Regions in a Mouse Model of Monocarboxylate Transporter 8 Deficiency. 2023.